SIGN UP
LOG IN
C
CPIX
Cumberland Pharmaceuticals Inc
4.97
0.13+2.58%After Hours: 4.970 0.00 0.00%16:05 04/25 EDT
OPEN/PREV CLOSE4.870/4.845
TODAY RANGE4.870-5.04
VOL17.10K
MARKET CAP69.42M
52 WEEK RANGE1.040-7.25
AVG VOL (3M)1.44M
% TURNOVER0.12%
TURNOVER--
P/E (TTM)-10.7833
% RANGE3.51%
EPS(TTM)-0.4609
P/E(FORWARD)35.50
P/B3.034
BVPS1.638
DIVIDEND--
P/S1.831
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP38.55M
SHARES OUTSTANDING13.97M
NEXT EARNINGS05/05-05/09
FREE FLOAT7.76M
LOT SIZE1
EX-DIV DATE--
News
Press Releases
Financial Reports
Profile
Simply Wall St·04/18 10:22
Cumberland Pharmaceuticals' (NASDAQ:CPIX) growing losses don't faze investors as the stock swells 18% this past week
Benzinga·03/21 21:05
12 Health Care Stocks Moving In Friday's After-Market Session
Press release·03/07 22:31
Form 10-K: Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
TipRanks·03/06 00:32
Cumberland Pharmaceuticals: Key Insights from Earnings Call
TipRanks·03/05 04:10
Cumberland Pharmaceuticals Reports Revenue Growth and Strategic Advances
Dow Jones·03/04 21:50
*Cumberland Pharma 4Q Rev $10.4M >CPIX
Seeking Alpha·03/04 21:16
Cumberland Pharmaceuticals Non-GAAP EPS of -$0.02, revenue of $10.43M
Dow Jones·03/04 21:05
*Cumberland Pharma 4Q Loss/Shr 14c >CPIX
Dow Jones·03/04 21:05
Press Release: Cumberland Pharmaceuticals Reports -2-
Dow Jones·03/04 21:05
Press Release: Cumberland Pharmaceuticals Reports -3-
Dow Jones·03/04 21:05
Press Release: Cumberland Pharmaceuticals Reports -4-
Same Industry
Name/Symbol
Change%
Price
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
② More than 40M Downloads Globally : data based on Webull Technologies Limited's internal statistics as of July 14, 2023.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
② More than 40M Downloads Globally : data based on Webull Technologies Limited's internal statistics as of July 14, 2023.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.